Name | Number of supported studies | Average coverage | |
---|---|---|---|
naive B cell | 12 studies | 20% ± 4% | |
B cell | 11 studies | 21% ± 4% | |
plasma cell | 6 studies | 32% ± 5% | |
memory B cell | 5 studies | 19% ± 2% | |
plasmablast | 4 studies | 34% ± 18% | |
ciliated cell | 4 studies | 21% ± 3% | |
endothelial cell | 4 studies | 20% ± 4% | |
regulatory T cell | 4 studies | 17% ± 1% | |
plasmacytoid dendritic cell | 4 studies | 21% ± 4% | |
epithelial cell | 3 studies | 27% ± 8% | |
fibroblast | 3 studies | 20% ± 4% | |
macrophage | 3 studies | 16% ± 1% | |
dendritic cell | 3 studies | 29% ± 10% | |
basal cell | 3 studies | 19% ± 2% | |
astrocyte | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 588.32 | 359 / 359 | 100% | 3.06 | 285 / 286 |
esophagus | 100% | 534.03 | 1445 / 1445 | 99% | 3.14 | 182 / 183 |
brain | 99% | 627.57 | 2628 / 2642 | 100% | 3.29 | 703 / 705 |
lung | 100% | 661.55 | 577 / 578 | 99% | 2.73 | 1145 / 1155 |
intestine | 100% | 744.20 | 966 / 966 | 99% | 2.95 | 520 / 527 |
thymus | 100% | 810.26 | 653 / 653 | 98% | 3.09 | 593 / 605 |
pancreas | 100% | 463.73 | 327 / 328 | 98% | 2.96 | 175 / 178 |
breast | 100% | 680.67 | 459 / 459 | 97% | 3.11 | 1083 / 1118 |
prostate | 100% | 669.02 | 245 / 245 | 96% | 2.47 | 481 / 502 |
ovary | 100% | 787.51 | 180 / 180 | 96% | 2.35 | 411 / 430 |
kidney | 100% | 581.76 | 89 / 89 | 95% | 2.72 | 859 / 901 |
bladder | 100% | 687.10 | 21 / 21 | 95% | 2.46 | 478 / 504 |
skin | 100% | 531.38 | 1808 / 1809 | 93% | 2.48 | 440 / 472 |
adrenal gland | 100% | 711.22 | 258 / 258 | 90% | 3.13 | 207 / 230 |
uterus | 100% | 708.51 | 170 / 170 | 89% | 1.94 | 409 / 459 |
liver | 100% | 341.48 | 225 / 226 | 53% | 0.96 | 215 / 406 |
adipose | 100% | 642.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 989.46 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 634.34 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 729.37 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 514.30 | 846 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 3.92 | 28 / 29 |
peripheral blood | 96% | 742.37 | 890 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 1.59 | 40 / 45 |
eye | 0% | 0 | 0 / 0 | 88% | 2.04 | 70 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060322 | Biological process | head development |
GO_0044782 | Biological process | cilium organization |
GO_2000369 | Biological process | regulation of clathrin-dependent endocytosis |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0005515 | Molecular function | protein binding |
Gene name | CCDC32 |
Protein name | Coiled-coil domain-containing protein 32 Coiled-coil domain containing 32 |
Synonyms | C15orf57 hCG_1999239 |
Description | FUNCTION: Regulates clathrin-mediated endocytsois of cargos such as transferrin probably through the association and modulation of adaptor protein complex 2 (AP-2) . Has a role in ciliogenesis (By similarity). Required for proper cephalic and left/right axis development . . |
Accessions | ENST00000560305.5 ENST00000558750.5 [Q9BV29-2] H0YLI5 ENST00000558918.1 ENST00000416810.7 [Q9BV29-1] A0A8V8TLS2 H0YMC0 ENST00000558113.5 ENST00000559103.1 ENST00000698443.1 Q9BV29 ENST00000559291.5 [Q9BV29-1] ENST00000559153.5 [Q9BV29-1] ENST00000559911.5 ENST00000561011.5 [Q9BV29-3] H0YM19 ENST00000558871.1 [Q9BV29-3] H0YLN5 ENST00000358005.7 [Q9BV29-1] H0YN78 |